TPTX - Turning Point Therapeutics Inc. (TPTX) CEO Athena Countouriotis on Q2 2021 Results - Earnings Call Transcript
Turning Point Therapeutics, Inc. (TPTX) Q2 2021 Results Earnings Conference Call August 9, 2021, 04:30 PM ET Company Participants Jim Mazzola - Senior Vice President, Communication and Investor Relations Athena Countouriotis - President and Chief Executive Officer Paolo Tombesi - Executive Vice President and Chief Financial Officer Mohammad Hirmand - Executive Vice President and Chief Medical Officer Conference Call Participants Paul Choi - Goldman Sachs Michael Schmidt - Guggenheim Securities Matt Biegler - Oppenheimer David Nierengarten - Wedbush Securities Andrew Berens - SVB Leerink Zegbeh Jallah - ROTH Capital Partners Silvan Turkcan - JMP Securities Arlinda Lee - Canaccord Genuity Presentation Operator Thank you all for standing by, and welcome to the Turning Point Therapeutics Second Quarter 2021 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]. I would now like to hand the conference
For further details see:
Turning Point Therapeutics, Inc. (TPTX) CEO Athena Countouriotis on Q2 2021 Results - Earnings Call Transcript